Arkolith/Insider Trading/WGS/Form 4

Stueland Katherine

CHIEF EXECUTIVE OFFICER, DirectorGeneDx Holdings Corp. (WGS) · full profile →Form 4 · filed Mar 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.0M
Net Open-Market Flow
-$3.0M
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2026Sell(S)5K$62.33$319K120K
Mar 26, 2026Sell(S)13K$61.29$811K125K
Mar 26, 2026Option exercise(M)80K—$0138K
Mar 26, 2026Sell(S)10K$65.21$644K92K
Mar 26, 2026Sell(S)13K$63.28$849K107K
Mar 26, 2026Sell(S)5K$64.60$342K101K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 26, 2026Option exercise(M)80K—$0160K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001689575-26-000021) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML